The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Molecular and cellular neurosciences

• Publication date

  2005-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.MCN.2005.09.005PMID 16209928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue-Type Plasminogen Activator Crosses the Intact Blood-Brain Barrier by Low-Density Lipoprotein Receptor–Related Protein-Mediated Transcytosis

  2005cited by this paper
• Neurotrophin-3-induced PI-3 kinase/Akt signaling rescues cortical neurons from apoptosis.

  2004cited by this paper
• The complexity of tissue-type plasminogen activator: can serine protease inhibitors help in stroke management?

  2004cited by this paper
• Equivocal roles of tissue-type plasminogen activator in stroke-induced injury.

  2004cited by this paper
• Arginine 260 of the Amino-terminal Domain of NR1 Subunit Is Critical for Tissue-type Plasminogen Activator-mediated Enhancement of N-Methyl-D-aspartate Receptor Signaling*

  2004cited by this paper
• Laminin chain expression suggests that laminin-10 is a major isoform in the mouse hippocampus and is degraded by the tissue plasminogen activator/plasmin protease cascade during excitotoxic injury.

  2003cited by this paper
• Transforming growth factor α‐induced expression of type‐1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity

  2003cited by this paper
• Smad3-dependent induction of plasminogen activator inhibitor-1 in astrocytes mediates neuroprotective activity of transforming growth factor-β1 against NMDA-induced necrosis

  2002cited by this paper
• Adjuvant Treatment With Neuroserpin Increases the Therapeutic Window for Tissue-Type Plasminogen Activator Administration in a Rat Model of Embolic Stroke

  2002cited by this paper
• Smad3-dependent induction of plasminogen activator inhibitor-1 in astrocytes mediates neuroprotective activity of transforming growth factor-beta 1 against NMDA-induced necrosis.

  2002cited by this paper
• Basic principles in thrombolysis: regulatory role of plasminogen.

  2001cited by this paper
• The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling

  2001cited by this paper
• Neuroprotection Mediated by Glial Cell Line-Derived Neurotrophic Factor: Involvement of a Reduction of NMDA-Induced Calcium Influx by the Mitogen-Activated Protein Kinase Pathway

  2001cited by this paper
• Neuroserpin, a neuroprotective factor in focal ischemic stroke.

  2001cited by this paper
• Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis.

  2000cited by this paper
• Serine Protease Inhibitors: Novel Therapeutic Targets for Stroke?

  2000cited by this paper
• Transforming growth factor‐βl as a regulator of the serpins/t‐PA axis in cerebral ischemia

  1999cited by this paper
• Neuronal degeneration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection.

  1999cited by this paper
• Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice.

  1999cited by this paper
• Tissue plasminogen activator (tPA) increase neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice

  1998cited by this paper
• Up‐regulation of a serine protease inhibitor in astrocytes mediates the neuroprotective activity of transforming growth factor β1

  1998cited by this paper
• The Axonally Secreted Serine Proteinase Inhibitor, Neuroserpin, Inhibits Plasminogen Activators and Plasmin but Not Thrombin*

  1998cited by this paper
• Expression of Neuroserpin, an Inhibitor of Tissue Plasminogen Activator, in the Developing and Adult Nervous System of the Mouse

  1997cited by this paper
• Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin.

  1997cited by this paper
• Neuroserpin, a Brain-associated Inhibitor of Tissue Plasminogen Activator Is Localized Primarily in Neurons

  1997cited by this paper
• Neuroserpin, an axonally secreted serine protease inhibitor.

  1996cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• The plasminogen activator/plasmin system.

  1991cited by this paper
• Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation

  1988cited by this paper
• Tissue Plasminogen Activator: Reduction of Neurologic Damage After Experimental Embolic Stroke

  1988cited by this paper
• Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay.

  1987cited by this paper

• Neuroserpin, Tissue Plasminogen Activator, Brain-Derived Neurotrophic Factor and Interleukin-6 Serum Levels in Patients with Bipolar Disorder.

  2026cites this paper
• Biomarkers for early detection and monitoring of abnormal brain development in mild fetal growth restriction

  2025cites this paper
• Neuroserpin: A Potential Neuroprotective Agent in Mild Neonatal Hypoxic–Ischaemic Encephalopathy

  2025cites this paper
• Modeling and correction of protein conformational disease in iPSC-derived neurons through personalized base editing

  2024cites this paper
• The paradox of tPA in ischemic stroke: tPA knockdown following recanalization improves functional and histological outcomes.

  2024influential citation
• Modeling and Correction of Protein Conformational Disease in iPSC-derived Neurons through Personalized Base Editing

  2024cites this paper
• Brain-tumor-seeking and serpin-inhibiting outer membrane vesicles restore plasmin-mediated attacks against brain metastases.

  2024cites this paper
• The Janus face of endogenous neuronal tPA: promoting self-protection and worsening the death of neighboring neurons

  2024cites this paper
• Neuroserpin alleviates cerebral ischemia-reperfusion injury by suppressing ischemia-induced endoplasmic reticulum stress

  2024cites this paper
• Acute ischemic stroke in the clinic and the laboratory Targets for translational research.

  2024cites this paper
• Neuroserpin As an Adjuvant Therapy for Hypothermia on Brain Injury in Neonatal Hypoxic–Ischemic Rats

  2023cites this paper
• Serpin family proteins as potential biomarkers and therapeutic drugs in stroke: A systematic review and meta‐analysis on clinical/preclinical studies

  2023cites this paper
• TMT proteomics analysis of cerebrospinal fluid from patients with cerebral venous sinus thrombosis.

  2023cites this paper
• The probable role of tissue plasminogen activator/neuroserpin axis in Alzheimer’s disease: a new perspective

  2023cites this paper
• Role of SERPINI1 pathogenic variants in familial encephalopathy with neuroserpin inclusion bodies: A case report and literature review.

  2022cites this paper
• Quantitative proteomics analysis of human vitreous in rhegmatogenous retinal detachment associated with choroidal detachment by data-independent acquisition mass spectrometry

  2022cites this paper
• Low-intensity blast induces acute glutamatergic hyperexcitability in mouse hippocampus leading to long-term learning deficits and altered expression of proteins involved in synaptic plasticity and serine protease inhibitors.

  2022cites this paper
• Neuroserpin, a crucial regulator for axogenesis, synaptic modelling and cell–cell interactions in the pathophysiology of neurological disease

  2022cites this paper
• Fibrinolytic Serine Proteases, Therapeutic Serpins and Inflammation: Fire Dancers and Firestorms

  2021cites this paper
• Deficiency in Neuroserpin Exacerbates CoCl2 Induced Hypoxic Injury in the Zebrafish Model by Increased Oxidative Stress

  2021cites this paper
• Neuroserpin: structure, function, physiology and pathology

  2021cites this paper
• Neuroserpin extends the time window of tPA thrombolysis in a rat model of middle cerebral artery occlusion

  2020cites this paper
• The Neuroprotective Role of Neuroserpin in Ischemic and Hemorrhagic Stroke

  2020cites this paper
• The role of endogenous tissue-type plasminogen activator in neuronal survival after ischemic stroke: friend or foe?

  2019cites this paper
• Spinosin Attenuates Alzheimer’s Disease-Associated Synaptic Dysfunction via Regulation of Plasmin Activity

  2019cites this paper
• Proteome-wide characterization and biomarker identification of intracranial aneurysm

  2019cites this paper
• Serpinopathies

  2019cites this paper
• Neuroserpin expression during human brain development and in adult brain revealed by immunohistochemistry and single cell RNA sequencing

  2019cites this paper
• Physiological and pathological functions of neuroserpin: Regulation of cellular responses through multiple mechanisms.

  2017cites this paper
• Neuroprotective effect of neuroserpin in non-tPA-induced intracerebral hemorrhage mouse models

  2017cites this paper
• New thrombolytic strategy providing neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tissue-type plasminogen activator

  2017cites this paper
• Role of Serine Proteases and Inhibitors in Cancer

  2017cites this paper
• Neonatal Hypoxia Ischaemia: Mechanisms, Models, and Therapeutic Challenges

  2017influential citation
• Can the benefits of rtPA treatment for stroke be improved?

  2017cites this paper
• Glaucoma is associated with plasmin proteolytic activation mediated through oxidative inactivation of neuroserpin

  2017cites this paper
• Effects of neuroserpin on clinical outcomes and inflammatory markers in Chinese patients with acute ischemic stroke

  2017cites this paper
• The story of an exceptional serine protease, tissue-type plasminogen activator (tPA).

  2016cites this paper
• Editorial: The Role of the Plasminogen Activating System in Neurobiology

  2016cites this paper
• Neuroserpin Attenuates H2O2-Induced Oxidative Stress in Hippocampal Neurons via AKT and BCL-2 Signaling Pathways

  2016cites this paper
• Neuroprotective Effect of Neuroserpin in Oxygen-Glucose Deprivation- and Reoxygenation-Treated Rat Astrocytes In Vitro

  2015cites this paper
• Impacts of tissue-type plasminogen activator (tPA) on neuronal survival

  2015cites this paper
• The Dual Role of Serpins and Tissue-Type Plasminogen Activator During Stroke

  2015cites this paper
• Sterol metabolism regulates neuroserpin polymer degradation in the absence of the unfolded protein response in the dementia FENIB

  2013cites this paper
• The calmodulin-dependent protein kinase II inhibitor KN-93 protects rat cerebral cortical neurons from N-methyl-D-aspartic acid-induced injury

  2013cites this paper
• Plasminogen Activators in Ischemic Stroke

  2012cites this paper
• Tissue plasminogen activator-independent roles of neuroserpin in the central nervous system

  2012cites this paper
• Effect of neuroserpin in a neonatal hypoxic-ischemic injury model ex vivo.

  2012cites this paper
• Expression of neuroserpin, a selective inhibitor of tissue‐type plasminogen activator in the human skin

  2012cites this paper
• Neuroprotection by urokinase plasminogen activator in the hippocampus.

  2012cites this paper
• Experimental analysis of risk factors for ulcerative dermatitis in mice

  2012cites this paper
• Association between neuroserpin and molecular markers of brain damage in patients with acute ischemic stroke

  2011cites this paper
• Serine proteases, serine protease inhibitors, and protease-activated receptors: roles in synaptic function and behavior.

  2011cites this paper
• Brain protection in cardiac surgery

  2011cites this paper
• Molecules involved in chemical defence of the chicken egg.

  2011cites this paper
• Experimental Basis and Clinical Studies of Brain Protection in Pediatric Heart Surgery

  2011cites this paper
• Encephalopathy with Neuroserpin Inclusion Bodies Presenting as Progressive Myoclonus Epilepsy and Associated with a Novel Mutation in the Proteinase Inhibitor 12 Gene

  2011cites this paper
• Neuroprotective effect of neuroserpin in rat primary cortical cultures after oxygen and glucose deprivation and tPA.

  2011influential citation
• pH‐dependent stability of neuroserpin is mediated by histidines 119 and 138; Implications for the control of β‐sheet A and polymerization

  2010cites this paper
• The natural tissue plasminogen activator inhibitor neuroserpin and acute ischaemic stroke outcome

  2010cites this paper
• Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator.

  2010cites this paper
• Aprotinin Confers Neuroprotection by Reducing Apoptotic Cell Death

  2010cites this paper
• Potential Neuroprotective Strategies for Ischemic Injury

  2010cites this paper
• Regulation of matrix metalloproteinase-9 and tissue plasminogen activator activity by alpha-synuclein in rat primary glial cells.

  2010cites this paper
• Mechanisms underlying hypoxic ischemic injury to the developing brain : the significance of matrix metalloproteinase 2 and 9.

  2009cites this paper
• Conformational pathology of the serpins: themes, variations, and therapeutic strategies.

  2009cites this paper
• Optimal dose of aprotinin for neuroprotection and renal function in a piglet survival model.

  2009cites this paper
• Aprotinin protects the cerebral microcirculation during cardiopulmonary bypass

  2009cites this paper
• The 2.1-A crystal structure of native neuroserpin reveals unique structural elements that contribute to conformational instability.

  2009cites this paper
• Estudio del efecto neuroprotector de tratamientos farmacológicos en un modelo in vitro de lesión excitotóxica de médula espinal de rata basado en cultivos organotípicos

  2009cites this paper
• Aprotinin confers neuroprotection by reducing excitotoxic cell death.

  2008cites this paper
• Immunomodulatory effects of plasminogen activators on hepatic fibrogenesis

  2008cites this paper
• Matrix metalloproteinase-9 and urokinase plasminogen activator mediate interleukin-1-induced neurotoxicity.

  2008cites this paper
• Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin

  2008influential citation
• Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases

  2007cites this paper
• Differential Adult and Neonatal Response to Cerebral Ischemia-Hypoxia

  2007cites this paper
• Inflammation et infiltration monocytaire associées à la dégénérescence neuronale induite par un status epilepticus chez le rat

  2007cites this paper
• Expression of the serine protease inhibitor neuroserpin in cells of the human myeloid lineage

  2007cites this paper
• Mouse Model of In Situ Thromboembolic Stroke and Reperfusion

  2007cites this paper
• Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies.

  2007cites this paper
• Neurovascular Proteases in Brain Injury, Hemorrhage and Remodeling After Stroke

  2007cites this paper
• Purkinje neuron degeneration in nervous (nr) mutant mice is mediated by a metabolic pathway involving excess tissue plasminogen activator

  2006cites this paper
• Neural Stem Cells Rescue nervous Purkinje Neurons by Restoring Molecular Homeostasis of Tissue Plasminogen Activator and Downstream Targets

  2006cites this paper
• Tissue‐type plasminogen activator rescues neurones from serum deprivation‐induced apoptosis through a mechanism independent of its proteolytic activity

  2006cites this paper
• ETUDE DE L'AMPLIFICATION DE LA NEURODEGENERESCENCE EXCITOTOXIQUE PAR UNE DYSFONCTION MITOCHONDRIALE : IMPLICATIONS POUR LA MALADIE DE HUNTINGTON

  2006cites this paper